Group 1 - A class action lawsuit has been filed against Fermi Inc. on behalf of investors who acquired Fermi securities during the Class Period from October 1, 2025, to December 11, 2025 [1][2] - Fermi is headquartered in Amarillo, Texas, and aims to establish a network of large, grid-independent data centers powered by various energy sources, with its flagship project being "Project Matador" [3] - The lawsuit alleges that Fermi misled investors about tenant demand for Project Matador and the status of its funding, particularly regarding reliance on a single tenant's commitment [4] Group 2 - On December 12, 2025, Fermi disclosed that the first tenant for Project Matador had terminated a $150 million construction funding agreement, leading to a significant drop in Fermi's share price by nearly 34% [5] - Investors who purchased Fermi securities during the Class Period have until March 6, 2026, to seek appointment as lead plaintiff representatives [2]

Core Viewpoint - A class action lawsuit has been filed against Skye Bioscience, Inc. for allegedly misleading investors regarding the efficacy of its lead product candidate, nimacimab, during the specified Class Period [1][3]. Group 1: Lawsuit Details - The lawsuit is on behalf of investors who acquired Skye securities from November 4, 2024, to October 3, 2025 [1][2]. - Investors have until January 16, 2026, to seek appointment as lead plaintiff representatives [2]. Group 2: Company Background - Skye Bioscience, Inc. is a clinical-stage biotechnology company based in San Diego, focusing on treatments for obesity and metabolic diseases [2]. Group 3: Allegations - The complaint claims that Skye failed to disclose that the efficacy of nimacimab was lower than previously represented, leading to an overstatement of the drug's clinical and commercial potential [3]. Group 4: Stock Impact - Following the announcement on October 6, 2025, that the primary endpoint of the Phase 2a study was not met, Skye's stock price fell by $2.85 per share, a decline of 60%, closing at $1.90 [4].

Core Viewpoint - A class action lawsuit has been filed against Klarna Group plc on behalf of investors who acquired Klarna securities during the specified class period, alleging omissions in the IPO Registration Statement regarding potential increases in loss reserves [1][3]. Group 1: Lawsuit Details - The lawsuit claims that Klarna's IPO Registration Statement failed to disclose critical information about the potential increase in loss reserves following the IPO, which the defendants should have been aware of due to the risk profiles of their customers [3]. - The class period for the lawsuit is defined as September 7, 2025, through December 22, 2025, including shares issued during Klarna's September 2025 IPO [1][2]. - As of the lawsuit filing, Klarna shares were trading at $31.31, significantly lower than the IPO price of $40 [4]. Group 2: Investor Information - Investors who purchased Klarna securities during the class period have until February 20, 2026, to seek appointment as lead plaintiff representatives [2]. - The lawsuit is being handled by Berger Montague, a law firm specializing in complex civil litigation and class actions [5].

Core Viewpoint - A class action lawsuit has been filed against Coupang, Inc. for allegedly misleading investors about its cybersecurity practices during a specified period, leading to significant financial losses due to a data breach [1][2][3] Group 1: Lawsuit Details - The lawsuit is on behalf of investors who acquired Coupang securities from May 7, 2025, to December 16, 2025 [1] - Investors have until February 17, 2026, to seek appointment as lead plaintiff representative of the class [2] - The complaint claims that Coupang had inadequate cybersecurity measures, increasing the risk of a data breach [2] Group 2: Cybersecurity Incident - In November 2025, it was revealed that a data breach had compromised sensitive personal information of over 33 million customers [3] - Following the disclosures, Coupang's stock price experienced significant declines, culminating in the company's acknowledgment of the breach on December 16, 2025 [3] - This incident is noted as the largest cybersecurity event affecting South Korea to date [3]

Core Viewpoint - A class action lawsuit has been filed against Telix Pharmaceuticals Ltd. on behalf of investors who purchased its securities during the specified class period, alleging that the company made false or misleading statements regarding its business and operations [1][3]. Company Overview - Telix Pharmaceuticals Ltd. is a biopharmaceutical company based in Melbourne, Australia, focusing on the development of radiopharmaceuticals for cancer treatment [3]. Allegations - The lawsuit claims that Telix overstated progress on its prostate cancer therapeutic candidates [3]. - It is alleged that the quality and performance of the company's supply chain and partners were exaggerated [3]. - As a result of these misrepresentations, statements regarding the company's business, operations, and prospects were deemed false or misleading [3]. Investor Information - Investors who purchased Telix securities during the class period have until January 9, 2026, to seek appointment as lead plaintiff representatives [2].

Core Viewpoint - A class action lawsuit has been filed against Integer Holdings Corporation for allegedly misleading investors regarding its business operations and sales performance during the specified class period [1][3]. Group 1: Lawsuit Details - The lawsuit is on behalf of investors who acquired Integer securities from July 25, 2024, to October 22, 2025 [1][2]. - Investors have until February 9, 2026, to seek appointment as lead plaintiff representative [2]. Group 2: Allegations Against the Company - The complaint claims that Integer made misleading statements and omitted critical information about its business, including overstating its market position and failing to disclose a decline in sales of electrophysiology devices [3]. - Following the announcement of reduced sales guidance on October 23, 2025, Integer's stock price dropped by $35.22 per share, representing a decline of over 32% in one day [3].

Core Viewpoint - A class action lawsuit has been filed against StubHub Holdings, Inc. on behalf of investors who acquired StubHub securities during the specified class period, particularly related to the company's IPO [1][2]. Group 1: Lawsuit Details - The lawsuit claims that StubHub's IPO Registration Statement did not disclose significant changes in the timing of payments to vendors, which affected the company's free cash flow [3]. Group 2: Company Overview - StubHub, headquartered in New York City, is a leading platform for the resale of tickets for various live entertainment events, including sports, concerts, and theater performances [2].

Core Viewpoint - A class action lawsuit has been filed against Six Flags Entertainment Corp. on behalf of investors who acquired shares during the merger period with Cedar Fair L.P., alleging that the merger registration statement misrepresented the company's financial and operational condition [1][3]. Group 1: Lawsuit Details - The lawsuit claims that Six Flags had faced years of underinvestment, leading to significant capital requirements for its parks to remain competitive, which were not disclosed to investors [3]. - Investors who purchased Six Flags securities during the class period (July 1, 2024, to November 5, 2025) have until January 5, 2026, to seek appointment as lead plaintiff [2]. Group 2: Stock Performance - On the merger closing date, July 1, 2024, Six Flags stock was trading above $55 per share, but it subsequently declined to as low as $20, representing a 64% loss in value [4].

Core Viewpoint - A class action lawsuit has been filed against Six Flags Entertainment Corp. on behalf of investors who acquired shares during the specified Class Period, alleging that the merger with Cedar Fair L.P. was misrepresented regarding the company's operational and capital needs [1][3]. Group 1: Lawsuit Details - The lawsuit claims that the registration statement for the merger did not accurately reflect Six Flags' true operational and capital requirements, indicating a history of underinvestment that necessitated significant spending to maintain market share [3]. - Investors who purchased Six Flags securities during the Class Period have until January 5, 2026, to seek appointment as lead plaintiff representatives [2]. Group 2: Stock Performance - Following the merger's closure on July 1, 2024, Six Flags' stock price initially traded above $55 per share but subsequently plummeted to as low as $20, representing a nearly 64% decline [4].

Core Viewpoint - A class action lawsuit has been filed against Six Flags Entertainment Corp. by Berger Montague PC on behalf of investors who purchased shares during the specified class period, alleging that the merger with Cedar Fair L.P. was misrepresented in terms of the company's financial and operational condition [1][3]. Group 1: Lawsuit Details - The lawsuit claims that the registration statement and prospectus related to the merger did not accurately reflect Six Flags' financial and operational status, indicating a history of underinvestment in its parks [3]. - Investors who acquired Six Flags securities from July 1, 2024, to November 5, 2025, are eligible to seek appointment as lead plaintiff representative by January 5, 2026 [2]. Group 2: Stock Performance - On the merger's closing date, July 1, 2024, Six Flags stock was trading above $55 per share, but it subsequently plummeted to as low as $20, representing a decline of nearly 64% [4].